Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Investment in securities market are subject to market risks. Read all the related documents carefully before investing

End of Year Sale!
Grab Our Small Cap Recommendation
Service at a 60% Discount




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian equity markets continue to trade in green
Wed, 9 Oct 01:30 pm

Indian markets have expanded gains during the post noon trading session. Barring stocks from consumer durables sector, all the sectoral indices are trading in green. Realty and healthcare stocks are witnessing maximum buying interest.

BSE-Sensex is up by 143 points and NSE-Nifty is trading up by 40 points. While BSE Mid Cap is trading up by 0.66%, BSE Small Cap index is trading up by 0.49%.The rupee is trading at 61.82 to the US dollar.

Most of the MNC pharma stocks are trading in green with Sanofi India and Abbott India leading the pack of gainers. As per a financial daily, Glaxosmithkline Pharmaceuticals (GSK) Ltd has been impacted due to implementation of the pricing policy. Sales of the company might get hit on the bulk orders as the company has reduced its profit margins for the bulk buyers. Reportedly, major territories of India have stopped buying the company's drugs. Further it is also reported that, the retailers are using various tactics by not purchasing drugs from companies who have reduced their margins. The new pricing policy targets to curb prices of costly brands sold by drug makers in order to makes medicines more affordable. GSK was trading up by 0.13% at the time of writing.

Majority of the FMCG stocks are trading in the green with Marico and Kokuyo Camilin being among the major gainers. Colgate and Emami are among the few stocks trading in the red. As per a leading financial daily, Godrej Consumer Products Ltd (GCPL) forayed into the hair salon segment by acquiring 30% stake in premium hair salon chain B:Blunt. B:Blunt was started in 2005 and has 17 outlets spread across Mumbai, New Delhi, Hyderabad, Pune, Indore, Bangalore and Dubai. The company's hair care business encompasses hair colour, hair dye, mehendi and hair oil products. As part of its inorganic growth strategy, GCPL has acquired three hair care brands in South Africa. The company acquired the Rapidol brand in 2006 and the Kinky group in 2008. In 2011, the company acquired 51% stake in Darling Group Holdings, an African hair care company. In June 2014 quarter, GCPL reported a 24% growth in sales backed by double-digit growth in both domestic and international operations. GCPL stock is currently trading up by 1%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian equity markets continue to trade in green". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.